- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
N-Nitroso Lanreotide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.LANREOTIDE (lan REE oh tide) is used to reduce blood levels of growth hormone in patients with a condition called acromegaly. It also works to slow or stop tumor growth in patients with neuroendocrine tumors and treat carcinoid syndrome.This medicine works by reducing the amount of growth hormone that the body produces. This medicine is also used to treat neuroendocrine tumors from the stomach or bowels or pancreas (GEP-NET) that has spread or cannot be removed by surgery. Lanreotide injection is also used to treat carcinoid syndrome.N-Nitroso Lanreotide is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Lanreotide CAS NO:NA chemically represented as (4R,7S,10S,13R,16S,19R)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-13-((1-nitroso-1H-indol-3-yl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Lanreotide .We supply N-Nitroso Lanreotide with detailed characterization data compliance with regulatory guidelines.
| Product name | N-Nitroso Lanreotide |
| SRC CAT No | SRC-N014764 |
| CAS No | NA |
| Mol.F. | C54H68N12O11S2 |
| Mol.Wt. | 1125.3 |
| Related CAS No. | NA |
| Inv Status | Custom Synthesis |
